BCWorld Pharma

BCWorld Pharma is a South Korean pharmaceutical company specializing in the development of advanced drug delivery systems (DDS) and the manufacturing of high-value-added specialty medicines. The company is widely recognized for its proprietary technologies, including EmulFrag for long-acting microsphere injectables and GR-Sustained Release for gastro-retentive formulations. BCWorld Pharma operates state-of-the-art manufacturing facilities that comply with international GMP standards, offering CDMO services for complex dosage forms and highly potent drugs. Their core therapeutic focus spans central nervous system disorders, oncology, and circulatory diseases. Publicly traded on the KOSDAQ, the company continues to expand its global presence through strategic licensing and export partnerships.